ATE531821T1 - Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle - Google Patents

Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle

Info

Publication number
ATE531821T1
ATE531821T1 AT08163947T AT08163947T ATE531821T1 AT E531821 T1 ATE531821 T1 AT E531821T1 AT 08163947 T AT08163947 T AT 08163947T AT 08163947 T AT08163947 T AT 08163947T AT E531821 T1 ATE531821 T1 AT E531821T1
Authority
AT
Austria
Prior art keywords
comparing
expression level
judging whether
cancer cells
value
Prior art date
Application number
AT08163947T
Other languages
English (en)
Inventor
Yasuhiro Otomo
Kaduki Nakabayashi
Kayo Shoji
Hideki Takata
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Application granted granted Critical
Publication of ATE531821T1 publication Critical patent/ATE531821T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Urology & Nephrology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT08163947T 2007-09-20 2008-09-09 Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle ATE531821T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007243989A JP5303132B2 (ja) 2007-09-20 2007-09-20 がん細胞の存否を判定する方法及び装置

Publications (1)

Publication Number Publication Date
ATE531821T1 true ATE531821T1 (de) 2011-11-15

Family

ID=40048962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08163947T ATE531821T1 (de) 2007-09-20 2008-09-09 Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle

Country Status (6)

Country Link
US (1) US8053193B2 (de)
EP (1) EP2039782B1 (de)
JP (1) JP5303132B2 (de)
CN (1) CN101392291A (de)
AT (1) ATE531821T1 (de)
ES (1) ES2375399T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5851400B2 (ja) * 2010-06-16 2016-02-03 Ｌｓｉｐファンド運営合同会社 大腸腫瘍の検出方法
JP5138801B2 (ja) * 2011-07-22 2013-02-06 シスメックス株式会社 癌化情報提供方法および装置
RU2015151954A (ru) * 2013-05-07 2017-06-13 Нэшнл Кэнсер Сентер Способ предсказания рецидива рака желудка
CN104862309B (zh) * 2015-04-22 2018-08-07 复旦大学 一种特异性检测肿瘤标志物mucin 1的LAMP方法
KR102507489B1 (ko) * 2020-12-24 2023-03-08 가톨릭대학교 산학협력단 진단 분류 장치 및 방법
CN114107492B (zh) * 2021-01-07 2024-04-26 首都医科大学附属北京胸科医院 一种用于肿瘤分子分型、治疗用药评估的分子标志物及其检测引物和试剂盒
WO2022216756A1 (en) * 2021-04-06 2022-10-13 Grail, Llc Conditional tissue of origin return for localization accuracy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637687A (en) 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
PT1410011E (pt) * 2001-06-18 2011-07-25 Rosetta Inpharmatics Llc Diagnóstico e prognóstico de pacientes com cancro da mama
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002356033A1 (en) 2001-08-13 2003-03-03 Genetics Development Corporation A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
CA2498783A1 (en) 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusale M Method for detection of micro-metastasis
ATE355529T1 (de) 2003-08-20 2006-03-15 Sysmex Corp Probenanalysegerät und eine vorrichtung zur detektion von nukleinsäuren
CA2563074C (en) * 2004-04-09 2014-05-20 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
JP4719455B2 (ja) 2004-12-07 2011-07-06 シスメックス株式会社 直接核酸増幅方法用生体試料処理液および直接核酸増幅方法
US8535914B2 (en) 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
JP2007175021A (ja) 2005-12-28 2007-07-12 Sysmex Corp 大腸がんのリンパ節転移マーカー
JP5102450B2 (ja) 2006-01-27 2012-12-19 シスメックス株式会社 核酸増幅分析装置

Also Published As

Publication number Publication date
JP5303132B2 (ja) 2013-10-02
EP2039782A3 (de) 2009-06-17
ES2375399T3 (es) 2012-02-29
US8053193B2 (en) 2011-11-08
US20090081671A1 (en) 2009-03-26
CN101392291A (zh) 2009-03-25
EP2039782B1 (de) 2011-11-02
JP2009072111A (ja) 2009-04-09
EP2039782A2 (de) 2009-03-25

Similar Documents

Publication Publication Date Title
GB2484623A (en) Apparatus and method for quality assessment of downhole data
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
WO2005073408A3 (en) Small segments of dna determine animal identity and source
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
DE602007009395D1 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2013064605A3 (en) Generate percentage of positive cells for biomarkers by normalizing and autothresholding the image intensity produced by immunohistochemistry technique
PH12019502710A1 (en) Fgfr2 inhibitors for the treatment of cholangiocarcinoma
CO6351830A2 (es) Método para caracterizar secuencias en muestras de material genético
NZ620799A (en) Molecular diagnostic test for cancer
NZ611599A (en) Detection of genetic or molecular aberrations associated with cancer
EP3450540A4 (de) Vorrichtung zur kultivierung von nervenzellen, verfahren zur kultivierung von nervenzellen, kultivierte nervenzelle, verfahren zur analyse und identifizierung von protein in axonbündel und verfahren zur verwendung der nervenzelle
EP4054235A4 (de) Verfahren und vorrichtung zur messung von zellen sowie vorrichtung und speichermedium
MX2012002902A (es) Compensacion para diafonia espectral en amplificacion de acido nucleico multiplexado.
ATE521894T1 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
WO2011106738A3 (en) Use of tcr clonotypes as biomarkers for disease
BR112014025520A2 (pt) método para estimar características de uma formação
ATE514161T1 (de) Vorrichtung und verfahren zum berechnen eines fingerabdrucks eines audiosignals, vorrichtung und verfahren zum synchronisieren und vorrichtung und verfahren zum charakterisieren eines testaudiosignals
EP2039782A3 (de) Verfahren und Vorrichtung zur Beurteilung des Vorliegens oder Nichtvorliegens einer Krebszelle
MX2017006097A (es) Libs para caracterizacion de fluido de materiales porosos.
MX343167B (es) Metodos y composiciones para identificar y tratar lupus.
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis
ATE459002T1 (de) Verfahren zur einschätzung des risikos maligner tumorrezidive
WO2009085852A3 (en) Method and apparatus for improving performance of erasure sequence detection
ES2721477T3 (es) Materiales y métodos para evaluar la progresión del cáncer de próstata